TNBC is a heterogenous tumor where the cancer cells lack estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 gene (HER2) amplification (Kumar and Aggarwal, 2016). This evidence concerns the gene ERBB2 and neoplasm.